IRCT2016052228003N1已完成2 期
Evaluation of the effects of anti-TN-alpha (Infliximab) on necrosis, inflammation, fibrosis and overall survival in patients with cryptogenic cirrhosis.
Research center for infectious diseases of digestive system, research adjutancy of Ahvaz Jundishapur0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •existence of proved cryptogenic cirrhosis; lack of experience with infliximab treatment in cirrhosis due to it; having informed consent
- •Exclusion criteria: Decompensated cirrhosis; active or latent tuberculosis; patient's trend to leaving the study.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Effects and Safety of TNF alpha Inhibitors inRefractory Spondyloarthopathies: Observational Study.CTRI/2018/05/013958Department of Pharmacology Institute of Postgraduate Medical Education and Research Kolkata
已完成
不适用
The safety of anti-tumor necrosis factor-alpha (TNF-a) agents in pregnancy. An observational prospective multicenter study.P04.1Fetus and newborn affected by other maternal medicationDRKS00005036Pharmakoivigilanz- und Beratungszentrum für Embryonaltoxikologie, Charité Berlin625
已完成
不适用
Effect of anti-tumour necrosis factor alpha (TNFa) therapy on blood vessel health in patients with rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisRheumatoid arthritisISRCTN57761809niversity of Dundee (UK)90
进行中（未招募）
不适用
The effect of TNF alpha inhibition on the early clinical course of Polymyalgia Rheumatica (pilot study). - N/APolymyalgia rheumatica.MedDRA version: 8.1Level: LLTClassification code 10036099Term: Polymyalgia rheumaticaEUCTR2007-003009-28-DKDepartment of Rheumatology40
已完成
2 期
Infliximab effectiveness in COVID-19 patientsIRCT20201229049873N1Shahre-kord University of Medical Sciences40